Edit |   |
---|---|
Antigenic Specificity | IL23A, Human (Tildrakizumab biosimilar) |
Clone | Tildrakizumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL23A Recombinant Antibody (Tildrakizumab). Tildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union. |
Immunogen | n/a |
Other Names | Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab, Anti-Human IL23A Recombinant Antibody(Tildrakizumab), MK-3222, SCH900222, Antibody Drug Analogues, Monoclonal Antibody, YR1295, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1326244-10-3 |
Catalog # | YR1295 |
Price | please inquire |
Order / More Info | IL23A, Human (Tildrakizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |